RiaSTAP

Indicated For

congenital fibrinogen deficiency, afibrinogenemia, hypofibrinogenemia

About This Medication

# CSL Behring Patient Assistance Program Patient Guide: How to Get RiaSTAP at Low or No Cost RiaSTAP (fibrinogen concentrate (human)) is a vital medication used to treat congenital fibrinogen deficiency by replacing missing or low fibrinogen levels in the blood, helping prevent and control bleeding episodes.[1][5] The **CSL Behring Patient Assistance Program** offers this therapy **at no cost** to qualified patients who are uninsured, underinsured, or unable to afford their prescribed treatment, making life-saving care accessible without strict income limits.[1][5] ## About RiaSTAP **RiaSTAP** is an intravenous concentrate derived from human plasma, indicated for acute bleeding episodes and perioperative management in patients with congenital fibrinogen deficiency.[5] It works by providing the clotting protein fibrinogen, which is essential for blood to clot properly. Administered by a healthcare professional in a hospital or clinic setting, it typically requires infusion over 5-10 minutes, with dosing based on the patient's weight and fibrinogen levels.[5] Common side effects may include headache, nausea, or allergic reactions, so discuss risks with your doctor. Always follow your prescriber's instructions, as RiaSTAP must be used per its package insert.[2] This program ensures patients facing financial barriers can access RiaSTAP without delay, supporting better health outcomes during critical times.[1][5] ## Who Qualifies? The program targets **patients who are uninsured, underinsured, or cannot afford their prescribed RiaSTAP therapy**.[1][5] Unlike many assistance programs, there are **no specific income thresholds** listed, such as Federal Poverty Level (FPL) percentages or household size limits. Qualification focuses on financial need and medical necessity rather than rigid income guidelines.[1][5] You must be a **U.S. resident** (excluding Puerto Rico and other territories for some related programs).[2][4] Eligible patients typically include: - Those without any health insurance covering RiaSTAP. - Underinsured individuals facing high out-of-pocket costs. - Anyone whose financial situation prevents affording therapy, even with partial coverage.[1][5] Your doctor must confirm RiaSTAP is **medically necessary** with no free trial history contraindications.[2] Government insurance like Medicare or Medicaid may affect eligibility—see the Insurance Requirements section below.[2] ## Income Eligibility Breakdown The CSL Behring Patient Assistance Program stands out for its **flexible, case-by-case income evaluation** without published fixed thresholds.[1][5] Here's a comparison table highlighting this approach versus typical programs: | Household Size | Typical Program (e.g., 400-500% FPL) | CSL Behring PAP | Notes | |---------------|-------------------------------------|-----------------|-------| | Individual | ~$60,000-$75,000/year | Case-by-case | No fixed limit; focuses on ability to pay.[1][5] | | Couple | ~$80,000-$100,000/year | Case-by-case | Income docs reviewed holistically. | | Family of 3 | ~$100,000-$125,000/year | Case-by-case | Uninsured/underinsured prioritized.[1] | | Family of 4 | ~$120,000-$150,000/year | Case-by-case | Proof of financial hardship key. | *Table based on 2026 FPL estimates for illustration; CSL Behring does not use FPL cutoffs.* Submit income proof for personalized assessment.[3] ## Insurance Requirements This program is designed for **uninsured, underinsured, or those unable to afford therapy**.[1][5] Patients with **commercial insurance** may qualify if costs are prohibitive, but **government programs like Medicare, Medicaid, Tricare, or SCHIPs often disqualify** you, as product must be purchased from specialty pharmacies, hemophilia centers, or hospitals.[2] Check with program staff: call (800) 676-4266 to verify.[5] Related co-pay programs require commercial coverage and exclude Medicare.[4] ## Step-by-Step Application Process Applying is straightforward with **multiple methods** available.[1] Here's how: 1. **Consult Your Doctor**: Get a prescription for brand-name RiaSTAP and discuss medical necessity. Your prescriber completes key form sections.[2][3] 2. **Gather Documents**: Prepare the Patient Assistance Qualification Form, income proof (W2, pay stubs, notarized income letter), and prescription.[3] 3. **Submit Application**: - **Phone**: Call **(800) 676-4266** for guidance, enrollment help, or to start verbally.[1][5] - **Form Download**: Visit CSL Behring's site or request the form via phone; prescriber signs it.[2][3] - **Fax/Mail**: Send to provided address after phone consultation.[3] 4. **Program Review**: CSL Behring verifies eligibility, insurance status, and need. Expect case manager support.[1][7] 5. **Approval Notification**: If approved, medication ships free.[1] Your signature authorizes CSL Behring to check insurance and enroll you in support services.[2][6] ## Timeline and Delivery **Processing time** varies but aims for quick access; call for status updates.[1] Once approved, RiaSTAP is **shipped directly to your home or physician's office** via specialty pharmacy.[1] Related programs note enrollment verification upon criteria met.[8] Refills follow reauthorization if required—contact (800) 676-4266.[5] ## Alternatives if Denied If ineligible: - Explore **CSL Behring Assurance** for insurance lapses (call 866-415-2164).[8] - **Co-Pay Programs** for commercial insurance (888-508-6978).[4] - Other foundations like Patient Access Network or HealthWell. - State programs or hemophilia treatment centers. - Discuss generics/biosimilars (none listed for RiaSTAP).[1] Reapply if circumstances change.[1] ## Disclaimer This guide is for informational purposes based on available program details as of 2026.[1][5] Eligibility, terms, and availability can change; CSL Behring reserves rights to modify or end the program.[2] Always contact (800) 676-4266 or visit official sites for latest info. Not medical advice—consult your healthcare provider. Income estimates illustrative; actual qualification case-specific. Word count: 1028.

Program information last verified: March 30, 2026